Neogenomics Inc
Change company Symbol lookup
Select an option...
NEO Neogenomics Inc
VGI Virtus Global Multi-Sector Income Fund
FRME First Merchants Corp
V Visa Inc
VRAY ViewRay Inc
LLAP Terran Orbital Corp
RTX Raytheon Technologies Corp
PLUG Plug Power Inc
PNM PNM Resources Inc
PFE Pfizer Inc
Go

Health Care : Life Sciences Tools & Services | Small Cap Value
Company profile

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories. The Company operates through two segments: the Clinical Services Segment and the Pharma Services Segment. The Clinical Services segment provides various clinical testing services to community-based pathology practices, oncology practices, hospital pathology labs, reference labs, and academic centers with reimbursement from various payers, including client direct billing, commercial insurance, Medicare and other government payers, and patients. The Pharma Services segment supports pharmaceutical firms in their drug development programs by providing testing services and data analytics for clinical trials and research. It offers testing services, which include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC) and digital imaging, molecular testing and morphologic analysis. It operates testing laboratories in United States, Europe and Asia.

Postmarket

Last Trade
Delayed
$11.10
-0.22 (-1.94%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$11.32
Day's Change
0.37 (3.38%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
11.47
Day's Low
10.82
Volume
(Light)
Volume:
456,491

10-day average volume:
750,996
456,491
  • Prev Close
    10.95
  • Today's Open
    11.11
  • Day's Range
    10.82-11.47
  • Avg Vol (10-day)
    751.0K
  • Last (time)
    4:00p ET 01/26/23
  • Last (size)
    10
  • 52-Wk Range
    6.00 - 23.78
    LowHigh
  • (02/10/22 - 10/24/22)
    88.67%
  • 91.4%
  • Market Cap
    1.4B
  • Shares Outstanding
    126.3M
  • -1.32
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.1
  • 89.03
  • (% of float 01/15/23)
    3.64

Latest News

January 26, 2023
2:00 pm ET
Accesswire
12:38 pm ET
Newsfile
11:00 am ET
PR Newswire
5:45 am ET
PR Newswire
1:46 am ET
Newsfile
January 25, 2023
10:45 pm ET
Accesswire
6:16 pm ET
Accesswire
5:17 pm ET
Newsfile
11:00 am ET
Accesswire
5:45 am ET
PR Newswire
January 24, 2023
10:38 pm ET
Globe Newswire
10:21 pm ET
Newsfile
1:35 pm ET
Accesswire
1:00 pm ET
Globe Newswire
5:45 am ET
PR Newswire
1:45 am ET
PR Newswire
January 23, 2023
10:50 pm ET
Accesswire
9:00 pm ET
Globe Newswire
5:48 pm ET
Accesswire
4:04 pm ET
PR Newswire
1:16 pm ET
Newsfile
1:00 pm ET
Globe Newswire
11:49 am ET
Accesswire
11:44 am ET
Globe Newswire
11:02 am ET
Accesswire
5:45 am ET
PR Newswire
January 22, 2023
11:01 am ET
Newsfile
8:23 am ET
Accesswire
January 21, 2023
4:35 pm ET
Globe Newswire
January 20, 2023
10:50 pm ET
PR Newswire
5:45 pm ET
Accesswire
4:58 pm ET
PR Newswire
3:15 pm ET
Accesswire
10:00 am ET
Globe Newswire
5:45 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.